U.S. Nuclear Regulatory Commission
Request for OGC Interpretation of 10 CFR 35.25 (a), "Instructing the Supervised Individual"
HPPOS-303 PDR-9306220048
Title: Request for OGC Interpretation of 10 CFR 35.25 (a),
"Instructing the Supervised Individual"
See the memorandum from S. A. Treby to J. E. Glenn dated
February 1, 1991. This was written in response to an NMSS
memo requesting an OGC interpretation of the term
"instruction" in 10 CFR 35.25 (a), including "a
determination whether errors that result in a
misadministration or performance error leading to a
violation would be a violation of the supervision
requirement in 10 CFR 35.25." The determination as to
whether a particular incident violates the provisions of
the regulations, in Section 35.25, for example, can only be
made on a case-by-case basis, depending on the facts
involved. Therefore, the following discussion is meant to
provide general guidance only, in reference to the kinds of
incidents described in the NMSS memo, and might not
necessarily be dispositive when applied to an actual
incident. HPPOS-303 contains a related topic.
OGC has considered the provisions of Section 35.25 and the
relevant statements of consideration (SOC), and we agree
that any error in the administration of the intended dosage
of radiopharmaceutical or radiation that results in a
misadministration or performance error would not
necessarily be a violation of the supervision requirement.
On the other hand, whether or not an administration of
byproduct material is in accordance with the physician's
directions, if there is a failure to follow the
instructions of the supervising authorized user or the
procedures of the RSO or to comply with the NRC regulations
or license conditions, there would be a violation of
Section 35.25.
The "term" instruction is not defined in Part 35. The SOC
for Part 35 (51 FR 369322) discusses that term, in the
context of responding to comments on the proposed rule, In
particular, the SOC states, in the relevant part:
3. Instruction. Several commenters asked if instruction
for workers had to be in classroom lecture format. The NRC
recognizes that instruction can be in the form of lectures,
laboratory exercise, audiovisual packages, printed
handouts, preceptorials, or apprenticeships. The important
point here is not the format of the instruction but rather
that the instruction be retained and used by the worker.
To help correct misunderstandings, an opportunity for
questions and answers should be an integral portion of each
instruction module.
The NRC did not address the frequency of review sessions
because that judgement must be made on-site. If employees
are performing all their assigned tasks correctly, there is
no need to spent time reviewing procedures with the
employees. If instruction has not been followed by regular
use of the procedures taught, then review instruction is
probably necessary. If an employee is unable to do things
correctly, then review and continued close supervision, or
reassignment, is necessary.
The SOC discusses Section 35.25, "Supervision", as follows
(in relevant part):
The purpose of supervision is to provide assurance that
technologists and physicians do not use byproduct materials
in a manner that is contrary to the requirements of the
license, the regulations or this is hazardous to the public
health and safety .... NRC recognizes that medical
practice is regulated differently in each state, but that,
in the end, the physician is responsible for providing
quality health care. A prescriptive definition that
describes delegable tasks, timely response in case of
untoward events, and training requirements that are suited
for one setting may hinder the delivery of medical care in
another setting. The authorized user physician identified
on the license is responsible for delivering quality
medical care, and is best situated to determine what tasks
a certain physician or technologist is capable of
performing.
Under the final regulation, a licensee may delegate to
unnamed individuals performance of any task associated with
the medical use of byproduct material, from package receipt
through quality control, prescription, administration,
interpretation or follow-up for individual clinical
procedures, and radioactive waste disposal. The
delegations must be consistent with other institutional
requirements and the state's regulation of medicine ....
The licensee can not delegate responsibility to supervised
individuals. If a supervised individual, through
misunderstanding, negligence, or commission, acts contrary
to the requirements of the license, the regulations, or an
order, the licensee remains responsible.
The NRC believes this strikes the best balance between its
responsibility to assure the public health and safety and a
physician's responsibility to deliver quality medical care.
Section 35.25 obviously requires that the supervised
individual follow the instructions of the supervising
authorized user, follow the procedures established by the
RSO, and comply with the regulations and the license
condition with respect to the use of byproduct material.
If the supervised individual does not follow these
instructions or procedures, or fails to comply with the
regulations and the license conditions, then there would be
a violation of Section 35.25. Furthermore, if the
instruction or procedure is incorporated into the license,
then there would be a violation of the license, which might
be the more appropriate citation for enforcement action.
OGC does not interpret Section 35.25 so narrowly as to
limit its scope only to a failure to follow a specific
instruction, which if adhered to, would have prevented a
misadministration or other incident. The language in
Section 35.25 clearly requires that the supervised
individual also follow certain procedures, regulations, and
license conditions. A failure to follow any one of those
would be a violation of Section 35.25. Thus, if there was
a failure to follow the instruction of the supervising
authorized user, the procedures of the RSO, or to comply
with the regulations or license conditions, there would be
a violation of Section 35.25.
OGC does not believe that any error in the administration
of the intended dosage resulting in a misadministration or
other incident, absent the failure to follow an
instruction, or procedure or to comply with a regulation or
license condition, is a violation of Section 35.25. Such
an interpretation would negate the long standing position
of the NRC that the occurrence of a misadministration is
not, in and of itself, the basis for enforcement action,
unless there is a failure to timely and properly report the
misadministration as required in 10 CFR 35.33, or there is
a violation of other applicable requirements, such as might
be contained in a regulation or license condition.
Regulatory references: 10 CFR 35.25
Subject codes: 1.2, 1.4, 12.11, 12.19
Applicability: Byproduct Material

